The molecular diagnostics equipment provider has completed a $11.3m investment from China-based Autobio Diagnostics that was announced in December.
Diagnostics product manufacturer Autobio Diagnostics has closed €10m ($11.3m) in funding for Finland-headquartered molecular diagnostics technology developer Mobidiag.
Founed in 2000, Mobidiag provides technology that is used by clinical laboratories to detect infectious diseases including those that are currently resistance to antibiotics.
The company’s platform is designed to screen multiple or single pathogens within a period of approximately one hour, facilitating early treatment that can avoid the spread of infection.
The funds will be used to strengthen the company’s product…
